Financial Architects, Inc Sarepta Therapeutics, Inc. Transaction History

Financial Architects, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $561 - $759	-5 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $533 - $758	5 New	5 $1,000
Q1 2019 May 03, 2019	SELL	$106.67 - $151.68 $533 - $758	-5 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$71.74 - $153.69 $14,347 - $30,738	-200 Reduced 97.56%	5 $1,000
Q1 2018 Apr 23, 2018	BUY	$54.02 - $82.27 $10,804 - $16,454	200 Added 4000.0%	205 $15,000
Q3 2017 Nov 01, 2017	BUY	$35.73 - $47.15 $178 - $235	5	5 $0

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.